Diabetic gastroparesis: A review

Journal of Diabetes and its Complications

Volumn 10, Issue 2, 1996, Pages 113-122

  Nilsson, Per Henrik ^a  

^a CENTRAL HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CISAPRIDE; DOPAMINE RECEPTOR BLOCKING AGENT; ERYTHROMYCIN; METOCLOPRAMIDE;

CLINICAL FEATURE; DIABETES MELLITUS; DIAGNOSTIC TEST; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STOMACH PARESIS;

EID: 0029968923     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8727(96)00001-3     Document Type: Review

References (96)

1. Feldman M, Schiller LR: Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 98:378-384, 1983.
2. Kinsley BT, Gramm HF, Rolla A: Diabetic gastroparesis: A review. J Diabet Complications 5:207-217, 1991.
3. Rundles RW: Diabetic Neuropathy. General review of 125 cases. Medicine 24:116-160, 1945.
4. Kassander P: Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann Intern Med 48: 797-812, 1954.
5. Kelly KA: Gastric emptying of liquids and solids: Roles of proximal and distal stomach. Am J Physiol 239:G71-76, 1980.
6. Kelly KA: Motility of the stomach and gastroduodenal junction, in Johnson LR (ed), Physiology of the Gastrointestinal Tract. New York: Raven, 1981, pp. 393-410.
7. Houghton LA, Read NW, Heddle R: Relationship of the motor activity of the antrum, pylorus and duodenum to gastric emptying of a solid-liquid mixed meal. Gastroenterology 94:1285-1291, 1988.
8. McCallum RW: Role of motility in gastric emptying and gastroduodenal reflux, in Johnson AG (ed), Progress in the Treatment of Gastrointestinal Motility Disorders: The Role of Cisapride. Amsterdam: Excerpta Medica, 1988, pp. 99-112.
9. Horowitz M, Collins PJ, Shearman DJC: Disorders of gastric emptying in humans and use of radionuclide techniques. Arch Intern Med 145:1467-1472, 1985.
10. Meyer JH: Motility of the stomach and gastroduodenal junction, in Johnson LR (ed), Physiology of the Gastrointestinal Tract. New York: Raven, 1987, pp. 613-629.
11. Gentry P, Miller P: Nutritional considerations in a patient with gastroparesis. Diabetes Educ 15:374-376, 1989.
12. Peeters TL, Vantrappen G, Janssens J. Fasting plasma motilin levels are related to the interdigestive motility complex. Gastroenterology 78:286-293, 1980.
13. Bormans V, Peeters TL, Janssens J, Pearce D, Vandeweerd M, Vantrappen G: In man, only activity fronts that originate in the stomach correlate with motilin peaks. Scand J Gastroenterol 22:781-784, 1987.
14. Peeters TL, Bormans V, Vantrappen G: Comparison of motilin binding to crude homogenates of human and canine gastrointestinal smooth muscle tissue. Regul Pept 23:171-182, 1988.
15. Wright RA, Clemente R, Wathen R: Diabetic gastroparesis: an abnormality of gastric emptying of solids. Am J Med Sci 289:240-242, 1985.
16. Urbain JLC, Vekemans MC, Bouillon R, Van Cauteren J, Bex M, Mayeur SM, Van den Maegdenbergh V, Bataille G, Charkes ND, Malmud LS, De Roo M: Characterization of gastric antral motility disturbances in diabetes using a scintigraphic technique. J Nucl Med 34: 576-581, 1993.
17. Horowitz M, Harding PE, Maddox A, Maddern GJ, Collins PJ, Chatterton BE, Wishart J, Shearman DJC: Gastric and oesophagal emptying in insulin-dependent diabetes mellitus. J Gastroenterol Hepatol 1:97-113, 1986.
18. Urbain JLC, Vantrappen J, Janssens J, Van Cutsem E, Peeters T, De Roo M: Intravenous erythromycin dramatically accelerates gastric emptying in gastroparesis diabeticorum and normals and abolishes the emptying discrimination between solids and liquids. J Nucl Med 31:1490-1493, 1990.
19. Keshvarian A, Iber FL, Vaeth J: Gastric emptying in patients with insulin requiring diabetes mellitus. Am J Gastroenterol 82:29-35, 1987.
20. Camilleri M, Malagelada J-R, Brown ML, Becker G, Zinsmeister AR: Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol 249:G580-585, 1985.
21. Fox S, Behar J: Pathogensis of diabetic gastroparesis: A pharmacologic study. Gastroenterology 78:757-763, 1980.
22. Kawagishi T, Nishizawa Y, Okuno Y, Sekiya K, Morii H: Effect of cisapride on gastric empyting of indigestible solids and plasma motilin concentration in diabetic autonomic neuropathy. Am J Gastroenterol 88:933-938, 1993.
23. Mearin F, Camilleri M, Malagelada J: Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 90:1919-1925, 1986.
24. Goyal RK, Spiro HM: Gastrointestinal manifestations of diabetes mellitus. Med Clin North Am 55:1031-1044, 1971.
25. Sheiner HJ, Quinlan MF, Thompson IJ: Gastric motility and emptying in normal and post-vagotomy subjects. Gut 21:753-759, 1980.
26. Kristensson K, Nordborg C, Olsson Y, Sourander P: Changes in the vagus nerve in diabetes mellitus. Acta Pathol Microbiol Scand 79:684-685, 1971.
27. Guy RJ, Dawson JL, Garrett JR, Laws JW, Thomas PK, Sharma AK, Watkins PJ: Diabetic gastroparesis from autonomic neuropathy: Surgical considerations and changes in vagus nerve morphology. J Neurol Neurosurg Psychiatry 47:686-691, 1984.
28. Feldman M, Corbett DB, Ramsey EJ, Walsh JH, Richardson CT: Abnormal gastric function in longstanding insulin-dependent diabetic patients. Gastroenterology 77:12-17, 1979.
29. Achem-Karam SR, Funakoshi A, Vinik AI, Chung O: Plasma motilin concentration and interdigestive migrating motor complex in diabetic gastroparesis: Effect of metoclopramide. Gastroenterology 88:492-499, 1985.
30. Schmid R, Schusdziarra V, Allescher HD, Bofilias I, Buttermann G, Clasen M: Effects of motilin on gastric emptying in patients with diabetic gastroparesis. Diabetes Care 14:65-68, 1990.
31. Hilsted J. Pathophysiology in diabetic autonomic neuropathy: cardiovascular, hormonal and metabolic studies. Diabetes 31:730-737, 1982.
32. Valenzuela JE. Effects of intestinal hormones and peptides on intragastric pressure in dogs. Gastroenterology 71:766-769, 1976.
33. Mitsukawa T, Takemura J, Ogho S, Mizuta M, Li T, Kuribayashi T, Matsukura S: Gallbladder function and plasma cholecystokinin levels in diabetes mellitus. Am J Gastroenterol 85:981-985, 1990.
34. Yang R, Aram R, Chan L: Gastrointestinal tract complications of diabetes mellitus: Pathophysiology and management. Arch Intern Med 144:1251-1256, 1984.
35. Hirano T, Niijima A: Effects of 2-deoxy-D-glucose, lucose and insulin on efferent activity in gastric vagus nerve. Experientia 36:1197-1198, 1980.
36. Angerwall L, Dotevall G, Lehmann KE: The gastric mucosa in diabetes mellitus: A functional and histopathological study. Acta Med Scand 169:339-349, 1961.
37. Bojsen-Moller F, Gronbaeck P, Rostgaard J: Light microscopy of gastrointestinal and skin capillaries in diabetes mellitus. Diabetes 12:429-432, 1963.
38. Libersky S, Koch K, Atnip R, Stern RM: Ischemic gastroparesis: resolution after revascularization. Gastroenterology 99:252-257, 1990.
39. Aylett P: Gastric emptying and change in blood glucose level, as affected by blood glucose and insulin. Clin Sci 22:171-178, 1962.
40. Fraser RJ, Horowtiz M, Maddox AF, Harding PE, Chatterton BE, Dent J: Hyperglycemia slows gastric emptying in type 1 (insulin dependent) diabetes mellitus. Diabetologia 33:675-680, 1990.
41. Varis K: Diabetic Gastroparesis. Scand J Gastroenterol 24:897-903, 1989.
42. Gaber AO, Oxley D, Karas J, Cardoso S, Hathaway D, Shokouh-Amiri MH, Jensen SL, Abell TL: Changes in gastric emptying in recipients of successful combined pancreas-kidney transplants. Dig Dis 9:437-443, 1991.
43. Gramm HD, Reuter K, Costello P: The radiologic manifestations of diabetic gastric neuropathy and its differential diagnosis. Gastrointest Radiol 3:151-155, 1978.
44. Nimmo WS: Drugs, diseases and altered gastric emptying. Clin Pharmacokinet 1:189-203, 1976.
45. Stanghellini V, Malagelada J-R, Zinmeister AR, Go VLW, Kao PC: Effect of opiate and adrenergic blockers on the gut motor response to centrally acting stimuli. Gastroenterology 87:1104-1113, 1984.
46. Bojö L, Cassuto J, Nellgård P: Pain-induced inhibition of gastric motility is mediated by adrenergic and vagal non-adrenergic reflexes in the rat. Acta Physiol Scand 146:377-383, 1992.
47. Yuo CH, Lee KY, Chey WY, Menguy R: Electrogastrographic study of patients with unexplained nausea, bloating and vomiting. Gastroenterology 79:311-314, 1980.
48. Maddern GJ, Horowitz M, Jamieson GG, Chatterton BE, Collins PJ, Roberts-Thomson P: Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis. Gastroenterology 87:922-926, 1984.
49. McCallum RW, Berkowitz DM, Lerner E: Gastric emptying in patients with gastrooesophageal reflux. Gastroenterology 80:285-291, 1981.
50. Dubois A, Gross HA, Ebert MH, Castell DO: Altered gastric emptying in primary anorexia nervosa. Gastroenterology 77:319-323, 1979.
51. Perkel MS, Hersh T, Moore C, Davidson ED: Metoclopramide therapy in fifty five patients with delayed gastric emptying. Am J Gastroenterol 74:231-236, 1980.
52. Feldman M, Smith HJ, Simon TR: Gastric emptying of solid radiopaque markers: Studies in healthy subjects and diabetic patients. Gastroenterology 87:895-902, 1984.
53. Scarpello JHB, Barber DC, Hague RV, Cullen DR, Sladen GE: Gastric emptying of solid meals in diabetics. BMJ 2:671-673, 1976.
54. Malmud LS, Fisher RS, Knight LC, Rock E: Scintigrafic evaluation of gastric empyting. Semin Nucl Med 12:116-125, 1982.
55. 99mTc-tagged chicken liver: a new method for measuring the rate of gastric emptying of solid food. Am J Dig Dis 21: 296-304, 1976.
56. Kroop HS, Long WB, Alavi A, Hansell JR: Effect of water and fat on gastric emptying of solid meals. Gastroenterology 77:997-1000, 1979.
57. Carryer PW, Brown ML, Malagelada J-R, Carlson GL, McCall JT: Quantification of the fate of dietary fibers in humans by a newly developed radiolabeled fiber marker. Gastroenterology 82:1389-1394, 1982.
58. Lartigue S, Bizais Y, Bruley des Varannes S, Murat A, Pouliquen B, Glamiche JP: Inter-and intrasubject variability of solid and liquid gastric emptying parameters: A scintigrafic study in healthy subjects and diabetic patients. Dig Dis Sci 39:109-115, 1994.
59. Vogelberg KH, Dalugge A: Sonographic studies during drug treatment of diabetic gastroparesis. Dtsch Med Wochenschr 113:967-971, 1988.
60. Burgstaller M, Barthel S, Kasper H: Diabetic gastroparesis and gallbladder disease: Ultrasound diagnosis after multiple-component meals. Dtsch Med Wochenschr 117: 1868-1873, 1992.
61. Rothstein RD, Alavi A, Reynolds JC: Electrogastrography in patients with gastroparesis and effect of long term cisapride. Dig Dis Sci 38:1518-1524, 1993.
62. Heading RC, Nimmo J, Prescott LF, Tothill P: The dependence of paracetamol absorption on the rate of gastric emptying. Br J Pharmacol 47:415-421, 1973.
63. Holt S, Stewart MJ, Adam RJ, Heading RC: Alcohol absorption, gastric emptying and a breathanalyzer. Br J Clin Pharmacol 9:205-208, 1980.
64. Thompson DG, Wingate DL, Thomas M, Harrison D: Gastric emptying as a determinant of the oral glucose test. Gastroenterology 82:51-55, 1982.
65. Kendall BJ, McCallum RW: Gastroparesis and the current use of prokinetic drugs. Gastroenterologist 1:107-114, 1993.
66. McGregor IL, Gueller R, Watts HD, Meyer JH: The effect of acute hyperglycemia on gastric emptying. Gastroenterology 70:190-196, 1976.
67. McCallum RW: Review of the current status of prokinetic agents in gastroenterology. Am J Gastroenterol 80: 1008-1016, 1985.
68. Schulze-Delrieu D: Drug therapy: Metoclopramide. N Engl J Med 305:28-32, 1981.
69. Snape WJ, Battle WM, Schwartz SS, Braunstein SN, Goldstein HA, Alavi A: Metoclopramide to treat gastroparesis due to diabetes mellitus. Ann Intern Med 96:444-446, 1982.
70. Malagelada J-R: Gastric emptying disorders: Clinical significance and treatment. Drugs 24:353-359, 1982.
71. Sewell DD, Yoshinobu BH, Caligiuri MP, Jeste DV: Metoclopramide associated tardive dyskinesia in hemodialysis patients with diabetes mellitus: Two case reports. Gen Hosp Psychiatry 14:416-419, 1992.
72. Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS: Domperidone: A review of its pharmacological activity, pharmacokinetics and therapeutic efficiency in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs 24:360-400, 1982.
73. Koch KL, Stern RM, Stewart WR, Vasey MW: Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: Effect of long-term domperidone treatment. Am J Gastroenterol 84:1069-1075, 1989.
74. Horowitz M, Harding PE, Chatterton BE, Collins PJ, Shearman DJC: Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy. Dig Dis Sci 30:1-9, 1985.
75. Spirt MJ, Chan W, Thieberg M, Sachar DB. Neuroleptic malignant syndrome induced by domperidone. Dig Dis Sci 37:946-948, 1992.
76. Schuurkes JAJ, Akkermans LMA, Van Nueten JM. Stimulating effects of cisapride on antroduodenal motility in the conscious dog, in Roman C (ed), Gastrointestinal Motility. Lancaster, MTP, 1984, pp. 95-102.
77. Horowitz M, Maddox A, Harding PE, Maddern GJ, Chatterton BE, Wishart J, Shearman DJC: The effects of single-dose and chronic administration of cisapride on gastric and oesophageal emptying in insulin-dependent diabetes mellitus-a double-blind placebo-controlled study, in Johnson AG (ed), Progress in the Treatment of Gastrointestinal Motility Disorders: The Role of Cisapride. Amsterdam, Excerpta Medica, 1988, pp. 99-112.
78. Horowitz M, Maddox A, Harding PE, Maddern GJ, Chatterton BE, Wishart J, Shearman DJ: Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus. Gastroenterology 92:1899-1907, 1987.
79. Feldman M, Smith HJ: Effect of cisapride on gastric emptying of solids in patients with gastroparesis diabeticorum: A comparison with metoclopramide and placebo. Gastroenterology 92:171-174, 1987.
80. Lazarovits A, Page D: Intraperitoneal cisapride for the treatment of diabetics with gastroparesis and end-stage renal disease. Nephron 56:107-109, 1990.
81. Depoortere I, Peeters TL, Matthijs G, Vantrappen G: Macrolide antibiotics are motilin receptor agonists. Hepatogastroenterology 35:198, 1988.
82. 125I-motilin to duodenal muscle. Biochem Biophys Res Commun 150:877-882, 1988.
83. Janssens J, Peeters G, Vantrappen J, Tack J, Urbain JL, De Roo M, Muls E, Bouillon R: Improvement of gastric emptying in diabetic gastroparesis by erythromycin: Preliminary studies. N Engl JMed 322:1028-1030, 1990.
84. Richards RD, Davenport K, McCallum RW: The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol 88:203-207, 1993.
85. Tanis AA, Baggen MGA, Wiggers RH, Ouwendijk RJT: Side-effects of oral erythromycin for treatment of diabetic gastroparesis. Lancet 342:1431, 1993.
86. Galar P, Oliet A, Vigil A, Ortega O, Guijo G: Gastroparesis: An important cause of hospitalization in continuous peritoneal dialysis and the role of erythromycin. Perit Dial Int 13:S183-186, 1992.
87. Lossos IS, Mevorach D, Oren R: Thietylperazine treatment of gastroparesis diabeticorum. Ann Pharmacother 26:1016, 1992.
88. Falchuk K, Conlin D: The intestinal and liver complications of diabetes mellitus, in LaMont T (ed), Advances in Internal Medicine, volume 38. Mosby-Year Book, 1993, pp. 269-286.
89. Sacerdote AS: Topical clinidine and diabetic gastroparesis. Ann Intern Med 112:796, 1990.
90. Gould RJ, Fioravanti C, Cook PG, Solomon HF: A model of gastric emptying in cats shows solid emptying is promoted by MK-329: a CCK antagonist. J Nucl Med 31:1494-1499, 1990.
91. Scarpignato C, Varga G, Coradi C: The effect of CCK and antagonists on gastric emptying. J Physiol Paris 87: 291-300, 1993.
92. Yamada M, Hongo M, Okuno Y, Nishimura N, Ueno M, Kawakami H, Toyota T: Effect of AS-4370 on gastric motility in patients with diabetic autonomic neuropathy. J Smooth Muscle Res 28:153-158, 1992.
93. Wooten RL, Meriwether TW: Diabetic gastric atony: A clinical study. JAMA 176:1082-1087, 1961.
94. Yeung EY, MacPhayden N, Ho CS: Intractable gastroparesis: Treatment with percutaneous fluoroscopically guided gastrostomies. Am J Gastroenterol 87:651-654, 1992.
95. The DCCT group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993.
96. Reichard P, Nilsson B-Y, Rosenquist U: The effects of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993.